AAD's Dialogues in Dermatology

234 Epizód

1. February JAAD: A 10-year retrospective cohort study of ruxolitinib and association with non-melanoma skin cancer in polycythemia vera and myelofibrosis patients

   Közzétéve: 2022. 02. 07.
2. January JAAD: Comorbid obesity and history of diabetes are independently associated with poorer treatment response to biologics at 6-months: a prospective analysis in the Corrona Psoriasis Registry

   Közzétéve: 2022. 02. 07.
3. December JAAD: Clinical mimickers of calciphylaxis: A retrospective study

   Közzétéve: 2021. 12. 22.
4. Bonus: Best of AAD 2021 Summer Meeting

   Közzétéve: 2021. 12. 15.
5. COVID-19 Series: Cutaneous Manifestations of COVID-19 in Children

   Közzétéve: 2021. 11. 23.
6. COVID-19 Series: COVID-19 Vaccine Boosters for Dermatology Patients

   Közzétéve: 2021. 11. 23.
7. Titans of Dermatology Series: Dr. Ken Greer

   Közzétéve: 2021. 11. 03.
8. Bonus: DataDerm - Synergistic Access to Data (Part I: Academic Medical Center Integration and Onboarding)

   Közzétéve: 2021. 11. 03.
9. November JAAD: Analysis of Hidradenitis Suppurativa Hospitalizations: A Report From The National Inpatient Sample

   Közzétéve: 2021. 11. 01.
10. October JAAD: Is Melanoma Overdiagnosed? A Review of the Evidence

    Közzétéve: 2021. 10. 06.
11. September JAAD: Systematic Review and Meta-Analysis of Local Recurrence Rates of Head and Neck Cutaneous Melanomas after Wide Local Excision, Mohs Micrographic Surgery, or Staged Excision

    Közzétéve: 2021. 09. 24.
12. August JAAD: Comparative Safety of Systemic Immuno-modulatory Medications in Audits with Atopic Dermatitis

    Közzétéve: 2021. 09. 14.
13. Eating Well? The Link Between Nutrition and Your Skin’s Health: Sponsored by the Almond Board of California

    Közzétéve: 2021. 09. 10.
14. COVID-19 Series: COVID-19 Vaccine Hesitancy

    Közzétéve: 2021. 08. 03.
15. AAD Guidelines of Care: Managing Co-Morbidities Associated with Psoriasis

    Közzétéve: 2021. 07. 26.
16. July JAAD: Baricitinib in patients with moderate-to-severe atopic dermatitis: Results from a randomized monotherapy Phase 3 trial in the United States and Canada (BREEZE AD5)

    Közzétéve: 2021. 07. 14.
17. Practice Management Series: Prioritizing physician’s judgement in patient care; responding to non-medical switching patterns

    Közzétéve: 2021. 07. 07.
18. Titans of Dermatology Series: Dr. Dirk Elston

    Közzétéve: 2021. 07. 01.
19. Bonus: Best of VMX 2021

    Közzétéve: 2021. 06. 28.
20. Bonus: AIDS 40th Anniversary: Dermatology's Impact on HIV Disease

    Közzétéve: 2021. 06. 25.